TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Pharma Systems AB
Closing information (x1000 SEK)
| Closing information | 2025/06 (consolidated) | 2024/06 (consolidated) | 2023/06 (consolidated) |
| Turnover |
24,800
|
21,261
|
36,342 |
| Financial expenses |
175
|
247
|
216 |
| Earnings before taxes |
-1,816
|
-3,335
|
344 |
| EBITDA |
-932
|
-2,268
|
2,357 |
| Total assets |
21,061
|
23,345
|
22,846 |
| Current assets |
15,151
|
16,762
|
15,072 |
| Current liabilities |
5,407
|
5,965
|
3,862 |
| Equity capital |
14,266
|
14,272
|
14,277 |
| - share capital |
206
|
206
|
206 |
| Employees (average) |
25
|
29
|
34 |
Financial ratios
| Fiscal year | 2025/06 (consolidated) | 2024/06 (consolidated) | 2023/06 (consolidated) |
| Solvency |
67.7%
|
61.1%
|
62.5% |
| Turnover per employee |
992
|
733
|
1,069 |
| Profit as a percentage of turnover |
-7.3%
|
-15.7%
|
0.9% |
| Return on assets (ROA) |
-7.8%
|
-13.2%
|
2.5% |
| Current ratio |
280.2%
|
281.0%
|
390.3% |
| Return on equity (ROE) |
-12.7%
|
-23.4%
|
2.4% |
| Change turnover |
3,539
|
-15,081
|
8,065 |
| Change turnover % |
17%
|
-41% | |
| Chg. No. of employees |
-4
|
-5
|
32 |
| Chg. No. of employees % |
-14%
|
-15% |
Total value of public sale
| Fiscal year | 2025/06 (consolidated) | 2024/06 (consolidated) | 2023/06 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.